compounded semaglutide fda shortage injection resolved feb 21 2025 list As of February 21, 2025, the FDA Compound versions of GLP-1 drugs

The microdosing tirzepatide chart was built with this syringe type in mind

These medications are often used to support appetite control and metabolic health, but they also have risks and may not be appropriate for everyone

Im only a week and a half in and my bloating has gone down already Janet few 5.0 Really good

[1] When to Seek Medical Advice Seek immediate medical attention (call 999 or attend A&E) if you experience: Signs of severe allergic reaction (anaphylaxis) : difficulty breathing, swelling of face/lips/tongue/throat, severe rash or hives, rapid pulse, dizziness or fainting Contact NHS 111 or seek urgent GP advice if you develop: Severe, persistent abdominal pain (possibly radiating to the back), with or without vomiting, which may indicate pancreatitis [1] Severe upper right abdominal pain, fever, or yellowing of skin or eyes (jaundice), which may suggest gallbladder problems Severe or persistent gastrointestinal symptoms preventing adequate fluid or food intake Signs of dehydration (dark urine, dizziness, reduced urination, extreme thirst) Contact your GP if you notice: Persistent injection site reactions lasting more than one week Signs of infection at injection sites (increasing warmth, spreading redness, pus, fever) Recurrent hypoglycaemia if taking diabetes medications Unexplained visual changes or severe headaches A lump or swelling in the neck, persistent hoarseness, difficulty swallowing, or shortness of breath Symptoms of depression or suicidal thoughts (rare but reported) Routine follow-up with your prescribing clinician is essential for monitoring treatment response, managing side effects, and adjusting doses appropriately

E.HickeyJ